Dr. Regenbogen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5303 Elliot Dr
Ypsilanti, MI 48197Phone+1 734-712-1000Fax+1 734-712-1012
Education & Training
Washington University in St. Louis School of MedicineResidency, 2010 - 2013
University College of Dublin National Univ SOMClass of 2010
Certifications & Licensure
FL State Medical License 2022 - Present
MI State Medical License 2017 - 2028
MO State Medical License 2013 - 2022
Publications & Presentations
PubMed
- 55 citationsRilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia.David J Kuter, Merlin Efraim, Jiri Mayer, Marek Trněný, Vickie McDonald
The New England Journal of Medicine. 2022-04-14 - 10 citationsPacritinib to inhibit JAK/STAT signaling in refractory metastatic colon and rectal cancer.Thomas Regenbogen, Ling Chen, Kathryn Trinkaus, Andrea Wang-Gillam, Benjamin R. Tan
Journal of Gastrointestinal Oncology. 2017-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
